Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

Monoclonal Antibodies Against Amyloid Beta Peptides


详细技术说明

Researchers at UC Irvine’s MIND Institute developed a set of seven hybridoma cell lines that produce monoclonal antibodies specifically against Aβ1-42. Antibodies 124-12, 02-5, 04-3, 55-7, and 56-2 recognize the epitope that resides within the N-terminal amino acids 1-15 of Aβ1-42 peptide. They were tested on western blotting and immunohistochemistry during the development. Antibody 55-7 was also tested as a capture antibody for ELISA. Antibody1313 was made specifically against the Aβx-40 c-terminal CVGGVV peptide. It shows high specificity and reactivity for Aβx-40 and was tested for western blotting, immunohistochemical staining, and ELISA detection antibody purposes. Antibody 1313 also shows significant therapeutically effect in treatment of APP/Tg2576 mouse model of AD. The final monoclonal antibody 2B4 was made reacting to the epitope CVGGVVIA of the c-terminus of Aβx-42 peptide. It has similar research applications as antibody 1313. The above antibodies are used for detection of amyloid beta peptides and valuable for AD research.


其他

Tech ID/UC Case

24265/2014-271-0


Related Cases

2014-271-0


国家/地区

美国

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版